nodes	percent_of_prediction	percent_of_DWPC	metapath
Propiomazine—CHRM3—muscle of abdomen—skin cancer	0.0987	0.134	CbGeAlD
Propiomazine—HRH1—nose—skin cancer	0.0762	0.104	CbGeAlD
Propiomazine—CHRM5—skin epidermis—skin cancer	0.0645	0.0877	CbGeAlD
Propiomazine—DRD1—nerve—skin cancer	0.0468	0.0636	CbGeAlD
Propiomazine—HTR2A—hindlimb—skin cancer	0.03	0.0408	CbGeAlD
Propiomazine—DRD2—nerve—skin cancer	0.0277	0.0376	CbGeAlD
Propiomazine—HTR2A—appendage—skin cancer	0.0257	0.035	CbGeAlD
Propiomazine—CHRM5—epithelium—skin cancer	0.021	0.0286	CbGeAlD
Propiomazine—CHRM5—skin of body—skin cancer	0.02	0.0272	CbGeAlD
Propiomazine—ADRA1D—epithelium—skin cancer	0.0188	0.0255	CbGeAlD
Propiomazine—HTR2A—nerve—skin cancer	0.0182	0.0248	CbGeAlD
Propiomazine—CHRM4—head—skin cancer	0.0167	0.0227	CbGeAlD
Propiomazine—HTR2A—endothelium—skin cancer	0.0155	0.0211	CbGeAlD
Propiomazine—HTR2A—blood vessel—skin cancer	0.0143	0.0195	CbGeAlD
Propiomazine—ADRA1D—female reproductive system—skin cancer	0.014	0.019	CbGeAlD
Propiomazine—CHRM5—head—skin cancer	0.013	0.0177	CbGeAlD
Propiomazine—HRH1—nipple—skin cancer	0.0124	0.0169	CbGeAlD
Propiomazine—ADRA1B—head—skin cancer	0.0119	0.0162	CbGeAlD
Propiomazine—ADRA1D—head—skin cancer	0.0117	0.0158	CbGeAlD
Propiomazine—DRD1—head—skin cancer	0.0111	0.0151	CbGeAlD
Propiomazine—ADRA1A—epithelium—skin cancer	0.0108	0.0147	CbGeAlD
Propiomazine—HTR2C—female reproductive system—skin cancer	0.0103	0.014	CbGeAlD
Propiomazine—HTR2A—neck—skin cancer	0.0103	0.0139	CbGeAlD
Propiomazine—CHRM1—female reproductive system—skin cancer	0.00975	0.0133	CbGeAlD
Propiomazine—CHRM2—head—skin cancer	0.00895	0.0122	CbGeAlD
Propiomazine—HRH1—connective tissue—skin cancer	0.0088	0.012	CbGeAlD
Propiomazine—CHRM3—female reproductive system—skin cancer	0.00873	0.0119	CbGeAlD
Propiomazine—HTR2C—head—skin cancer	0.00863	0.0117	CbGeAlD
Propiomazine—HRH1—epithelium—skin cancer	0.00835	0.0113	CbGeAlD
Propiomazine—ADRA1A—lymphoid tissue—skin cancer	0.00831	0.0113	CbGeAlD
Propiomazine—CHRM1—head—skin cancer	0.00815	0.0111	CbGeAlD
Propiomazine—HTR2A—connective tissue—skin cancer	0.00735	0.00998	CbGeAlD
Propiomazine—CHRM3—head—skin cancer	0.00729	0.00991	CbGeAlD
Propiomazine—HRH1—mammalian vulva—skin cancer	0.00724	0.00984	CbGeAlD
Propiomazine—HTR2A—epithelium—skin cancer	0.00697	0.00948	CbGeAlD
Propiomazine—ADRA1A—head—skin cancer	0.00669	0.0091	CbGeAlD
Propiomazine—DRD2—head—skin cancer	0.00656	0.00892	CbGeAlD
Propiomazine—HRH1—female reproductive system—skin cancer	0.0062	0.00843	CbGeAlD
Propiomazine—HRH1—head—skin cancer	0.00518	0.00704	CbGeAlD
Propiomazine—HTR2A—female reproductive system—skin cancer	0.00518	0.00704	CbGeAlD
Propiomazine—HTR2A—head—skin cancer	0.00433	0.00588	CbGeAlD
Propiomazine—HRH1—lymph node—skin cancer	0.00363	0.00493	CbGeAlD
Propiomazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000209	0.000791	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—SUFU—skin cancer	0.000208	0.00079	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—SHH—skin cancer	0.000208	0.000787	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—RASA1—skin cancer	0.000206	0.000782	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—SUFU—skin cancer	0.000205	0.000777	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—SUFU—skin cancer	0.000205	0.000775	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—SUFU—skin cancer	0.000204	0.000773	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—PTGER4—skin cancer	0.000204	0.000772	CbGpPWpGaD
Propiomazine—DRD2—Circadian rythm related genes—TP53—skin cancer	0.000203	0.000771	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—SUFU—skin cancer	0.000203	0.00077	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—SUFU—skin cancer	0.000201	0.000763	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—SUFU—skin cancer	0.000201	0.000761	CbGpPWpGaD
Propiomazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.0002	0.000757	CbGpPWpGaD
Propiomazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.0002	0.000757	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—PTCH1—skin cancer	0.0002	0.000756	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—SMO—skin cancer	0.0002	0.000756	CbGpPWpGaD
Propiomazine—CHRM1—Circadian rythm related genes—TP53—skin cancer	0.000199	0.000754	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—PTCH1—skin cancer	0.000197	0.000746	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—SMO—skin cancer	0.000197	0.000746	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—PTGER4—skin cancer	0.000194	0.000736	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—PTGER4—skin cancer	0.000192	0.000726	CbGpPWpGaD
Propiomazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000191	0.000725	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—FOXO4—skin cancer	0.000191	0.000722	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—FOXO4—skin cancer	0.000188	0.000712	CbGpPWpGaD
Propiomazine—DRD2—Circadian rythm related genes—IL6—skin cancer	0.000186	0.000705	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—ENO2—skin cancer	0.000185	0.000702	CbGpPWpGaD
Propiomazine—CHRM1—Circadian rythm related genes—IL6—skin cancer	0.000182	0.00069	CbGpPWpGaD
Propiomazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000181	0.000687	CbGpPWpGaD
Propiomazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000181	0.000686	CbGpPWpGaD
Propiomazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.00018	0.000683	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—FOXO4—skin cancer	0.00018	0.000682	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—SHH—skin cancer	0.00018	0.000682	CbGpPWpGaD
Propiomazine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.00018	0.000681	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—RASA1—skin cancer	0.000179	0.000678	CbGpPWpGaD
Propiomazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000178	0.000673	CbGpPWpGaD
Propiomazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000174	0.000658	CbGpPWpGaD
Propiomazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000173	0.000656	CbGpPWpGaD
Propiomazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000173	0.000654	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—SHH—skin cancer	0.000172	0.000653	CbGpPWpGaD
Propiomazine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000172	0.000652	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—FOXO4—skin cancer	0.000172	0.00065	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—RASA1—skin cancer	0.000171	0.000649	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—PTCH1—skin cancer	0.000171	0.000647	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—SMO—skin cancer	0.000171	0.000647	CbGpPWpGaD
Propiomazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.00017	0.000644	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—FOXO4—skin cancer	0.000169	0.000641	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—PTGER4—skin cancer	0.000166	0.00063	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—PTCH1—skin cancer	0.000163	0.000619	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—SMO—skin cancer	0.000163	0.000619	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—PTGER4—skin cancer	0.000159	0.000603	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—SHH—skin cancer	0.000159	0.000602	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—RASA1—skin cancer	0.000158	0.000598	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—SHH—skin cancer	0.000156	0.000592	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—SHH—skin cancer	0.000156	0.000591	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—SHH—skin cancer	0.000156	0.000589	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—RASA1—skin cancer	0.000155	0.000589	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—RASA1—skin cancer	0.000155	0.000587	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—SHH—skin cancer	0.000155	0.000587	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—RASA1—skin cancer	0.000155	0.000586	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—RASA1—skin cancer	0.000154	0.000584	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—SHH—skin cancer	0.000154	0.000582	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—SHH—skin cancer	0.000153	0.00058	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—RASA1—skin cancer	0.000153	0.000578	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—RASA1—skin cancer	0.000152	0.000576	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—SMO—skin cancer	0.000151	0.000571	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—PTCH1—skin cancer	0.000151	0.000571	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—SMO—skin cancer	0.000148	0.000562	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—PTCH1—skin cancer	0.000148	0.000562	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—SMO—skin cancer	0.000148	0.00056	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—PTCH1—skin cancer	0.000148	0.00056	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—SMO—skin cancer	0.000147	0.000559	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—PTCH1—skin cancer	0.000147	0.000559	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—SMO—skin cancer	0.000147	0.000557	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—PTCH1—skin cancer	0.000147	0.000557	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—FOXO4—skin cancer	0.000147	0.000556	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—PTGER4—skin cancer	0.000147	0.000556	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—SMO—skin cancer	0.000146	0.000551	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PTCH1—skin cancer	0.000146	0.000551	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—SMO—skin cancer	0.000145	0.00055	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PTCH1—skin cancer	0.000145	0.00055	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—PTGER4—skin cancer	0.000144	0.000547	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—PTGER4—skin cancer	0.000144	0.000546	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—PTGER4—skin cancer	0.000144	0.000544	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—PTGER4—skin cancer	0.000143	0.000542	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PTGER4—skin cancer	0.000142	0.000537	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PTGER4—skin cancer	0.000141	0.000535	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—FOXO4—skin cancer	0.000141	0.000532	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—FOXO4—skin cancer	0.00013	0.000491	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—FOXO4—skin cancer	0.000127	0.000483	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—TERT—skin cancer	0.000127	0.000482	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—FOXO4—skin cancer	0.000127	0.000482	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—FOXO4—skin cancer	0.000127	0.00048	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—FOXO4—skin cancer	0.000126	0.000479	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—TERT—skin cancer	0.000126	0.000476	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—FOXO4—skin cancer	0.000125	0.000474	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—FOXO4—skin cancer	0.000125	0.000473	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—TERT—skin cancer	0.00012	0.000456	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—TERT—skin cancer	0.000115	0.000434	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—TERT—skin cancer	0.000113	0.000428	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—ERCC2—skin cancer	0.000108	0.000408	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—NRAS—skin cancer	0.000107	0.000406	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—NRAS—skin cancer	0.000106	0.000401	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—NRAS—skin cancer	0.000101	0.000384	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—BRAF—skin cancer	0.000101	0.000382	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—BRAF—skin cancer	9.95e-05	0.000377	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—TERT—skin cancer	9.81e-05	0.000371	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—NRAS—skin cancer	9.66e-05	0.000366	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—NRAS—skin cancer	9.53e-05	0.000361	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—BRAF—skin cancer	9.53e-05	0.000361	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—TERT—skin cancer	9.39e-05	0.000356	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—KRAS—skin cancer	9.23e-05	0.00035	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—KRAS—skin cancer	9.11e-05	0.000345	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—BRAF—skin cancer	9.08e-05	0.000344	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—BRAF—skin cancer	8.96e-05	0.000339	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—KRAS—skin cancer	8.72e-05	0.00033	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—TERT—skin cancer	8.65e-05	0.000328	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—TERT—skin cancer	8.52e-05	0.000323	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—TERT—skin cancer	8.5e-05	0.000322	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—TERT—skin cancer	8.47e-05	0.000321	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—TERT—skin cancer	8.44e-05	0.00032	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—TERT—skin cancer	8.36e-05	0.000317	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—TERT—skin cancer	8.34e-05	0.000316	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—KRAS—skin cancer	8.31e-05	0.000315	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—NRAS—skin cancer	8.26e-05	0.000313	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—KRAS—skin cancer	8.2e-05	0.000311	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—NRAS—skin cancer	7.91e-05	0.0003	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—HRAS—skin cancer	7.85e-05	0.000297	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—BRAF—skin cancer	7.77e-05	0.000294	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—HRAS—skin cancer	7.74e-05	0.000293	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—IL6—skin cancer	7.51e-05	0.000285	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—BRAF—skin cancer	7.43e-05	0.000282	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—HRAS—skin cancer	7.41e-05	0.000281	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—IL6—skin cancer	7.41e-05	0.000281	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—NRAS—skin cancer	7.29e-05	0.000276	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—NRAS—skin cancer	7.17e-05	0.000272	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—NRAS—skin cancer	7.16e-05	0.000271	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—NRAS—skin cancer	7.14e-05	0.00027	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—NRAS—skin cancer	7.11e-05	0.000269	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—KRAS—skin cancer	7.11e-05	0.000269	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—IL6—skin cancer	7.1e-05	0.000269	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—HRAS—skin cancer	7.07e-05	0.000268	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—NRAS—skin cancer	7.04e-05	0.000267	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—NRAS—skin cancer	7.03e-05	0.000266	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—HRAS—skin cancer	6.97e-05	0.000264	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—BRAF—skin cancer	6.85e-05	0.00026	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—KRAS—skin cancer	6.81e-05	0.000258	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—IL6—skin cancer	6.76e-05	0.000256	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—BRAF—skin cancer	6.74e-05	0.000255	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—BRAF—skin cancer	6.73e-05	0.000255	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—BRAF—skin cancer	6.71e-05	0.000254	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—BRAF—skin cancer	6.69e-05	0.000253	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—IL6—skin cancer	6.67e-05	0.000253	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—BRAF—skin cancer	6.62e-05	0.000251	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—BRAF—skin cancer	6.6e-05	0.00025	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—PTGS2—skin cancer	6.46e-05	0.000245	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—NRAS—skin cancer	6.34e-05	0.00024	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—KRAS—skin cancer	6.28e-05	0.000238	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—NRAS—skin cancer	6.25e-05	0.000237	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—KRAS—skin cancer	6.18e-05	0.000234	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—KRAS—skin cancer	6.16e-05	0.000233	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—KRAS—skin cancer	6.14e-05	0.000233	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—KRAS—skin cancer	6.12e-05	0.000232	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—KRAS—skin cancer	6.06e-05	0.00023	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—KRAS—skin cancer	6.05e-05	0.000229	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—HRAS—skin cancer	6.04e-05	0.000229	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—NRAS—skin cancer	5.99e-05	0.000227	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—HRAS—skin cancer	5.79e-05	0.000219	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—IL6—skin cancer	5.79e-05	0.000219	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—NRAS—skin cancer	5.71e-05	0.000216	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—NRAS—skin cancer	5.63e-05	0.000213	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—IL6—skin cancer	5.54e-05	0.00021	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—KRAS—skin cancer	5.45e-05	0.000207	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—KRAS—skin cancer	5.38e-05	0.000204	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—HRAS—skin cancer	5.33e-05	0.000202	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—HRAS—skin cancer	5.25e-05	0.000199	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—HRAS—skin cancer	5.24e-05	0.000198	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—HRAS—skin cancer	5.22e-05	0.000198	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—HRAS—skin cancer	5.2e-05	0.000197	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—HRAS—skin cancer	5.15e-05	0.000195	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—KRAS—skin cancer	5.15e-05	0.000195	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—HRAS—skin cancer	5.14e-05	0.000195	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—IL6—skin cancer	5.11e-05	0.000193	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—IL6—skin cancer	5.02e-05	0.00019	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—IL6—skin cancer	5.01e-05	0.00019	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—IL6—skin cancer	5e-05	0.000189	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—IL6—skin cancer	4.98e-05	0.000189	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—IL6—skin cancer	4.93e-05	0.000187	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—IL6—skin cancer	4.92e-05	0.000186	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—KRAS—skin cancer	4.91e-05	0.000186	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—NRAS—skin cancer	4.88e-05	0.000185	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—TP53—skin cancer	4.85e-05	0.000184	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—KRAS—skin cancer	4.84e-05	0.000184	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—TP53—skin cancer	4.78e-05	0.000181	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—NRAS—skin cancer	4.67e-05	0.000177	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—HRAS—skin cancer	4.64e-05	0.000176	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—TP53—skin cancer	4.58e-05	0.000173	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—HRAS—skin cancer	4.57e-05	0.000173	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—IL6—skin cancer	4.44e-05	0.000168	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—HRAS—skin cancer	4.38e-05	0.000166	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—IL6—skin cancer	4.38e-05	0.000166	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—TP53—skin cancer	4.36e-05	0.000165	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—NRAS—skin cancer	4.31e-05	0.000163	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—TP53—skin cancer	4.31e-05	0.000163	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—NRAS—skin cancer	4.24e-05	0.000161	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—NRAS—skin cancer	4.23e-05	0.00016	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—NRAS—skin cancer	4.22e-05	0.00016	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—NRAS—skin cancer	4.2e-05	0.000159	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—KRAS—skin cancer	4.2e-05	0.000159	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—IL6—skin cancer	4.19e-05	0.000159	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—HRAS—skin cancer	4.17e-05	0.000158	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—NRAS—skin cancer	4.16e-05	0.000158	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—NRAS—skin cancer	4.15e-05	0.000157	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—HRAS—skin cancer	4.12e-05	0.000156	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—KRAS—skin cancer	4.02e-05	0.000152	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—IL6—skin cancer	3.99e-05	0.000151	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—IL6—skin cancer	3.94e-05	0.000149	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—TP53—skin cancer	3.73e-05	0.000141	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—KRAS—skin cancer	3.71e-05	0.00014	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—KRAS—skin cancer	3.65e-05	0.000138	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—KRAS—skin cancer	3.64e-05	0.000138	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—KRAS—skin cancer	3.63e-05	0.000137	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—KRAS—skin cancer	3.62e-05	0.000137	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—KRAS—skin cancer	3.58e-05	0.000136	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—TP53—skin cancer	3.57e-05	0.000135	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—KRAS—skin cancer	3.57e-05	0.000135	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—HRAS—skin cancer	3.57e-05	0.000135	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—HRAS—skin cancer	3.42e-05	0.000129	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—IL6—skin cancer	3.42e-05	0.000129	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—TP53—skin cancer	3.3e-05	0.000125	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—IL6—skin cancer	3.27e-05	0.000124	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—TP53—skin cancer	3.24e-05	0.000123	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—TP53—skin cancer	3.24e-05	0.000123	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—TP53—skin cancer	3.22e-05	0.000122	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—TP53—skin cancer	3.21e-05	0.000122	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—TP53—skin cancer	3.18e-05	0.000121	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—TP53—skin cancer	3.17e-05	0.00012	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—HRAS—skin cancer	3.15e-05	0.000119	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—HRAS—skin cancer	3.1e-05	0.000117	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—HRAS—skin cancer	3.09e-05	0.000117	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—HRAS—skin cancer	3.08e-05	0.000117	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—HRAS—skin cancer	3.07e-05	0.000116	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—HRAS—skin cancer	3.04e-05	0.000115	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—HRAS—skin cancer	3.04e-05	0.000115	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—IL6—skin cancer	3.02e-05	0.000114	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—IL6—skin cancer	2.97e-05	0.000112	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—IL6—skin cancer	2.96e-05	0.000112	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—IL6—skin cancer	2.95e-05	0.000112	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—IL6—skin cancer	2.94e-05	0.000111	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—IL6—skin cancer	2.91e-05	0.00011	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—IL6—skin cancer	2.91e-05	0.00011	CbGpPWpGaD
